Broker’s call: Natco Pharma (Buy)
Target: ₹1,206 CMP: ₹883.50 In the latest quarter, the company’s revenue reached ₹1,140.50 crore, marking a notable 27 per cent
Continue readingThe Number One Finance & Business Blog!
Target: ₹1,206 CMP: ₹883.50 In the latest quarter, the company’s revenue reached ₹1,140.50 crore, marking a notable 27 per cent
Continue readingRecently, one common factor that impacted traders and investors in the F&O segment was the trading ban on individual stock derivatives. For
Continue readingTarget: ₹5,955 CMP: ₹6,920.85 Atul’s FY22 performance was bolstered by a strong showing in the domestic as well as export
Continue readingRattanIndia Enterprises saw an 8.46 per cent upswing in its share value as its subsidiary, Revolt Intellicorp Pvt Ltd, settled
Continue readingThe public issue of Vishnu Prakash R Punglia Ltd that opened on Thursday, has received a strong response from HNIs
Continue readingTarget: ₹602 CMP: ₹656.60 KEC International order book stood at ₹30,125 crore as on June 30, 2023 (excluding L1 positions
Continue readingIt is raining blocks on deal street — with shares worth $1.2 billion being transacted in a single day. Private
Continue readingIndian shares reversed intraday gains on Thursday, as a slide in Reliance Industries overpowered the rise in IT stocks, while
Continue readingThe real estate sector is booming, and realty stocks are reaping the benefits, with shares of majority of the stocks
Continue readingThe ₹351-crore initial public offering of Aeroflex Industries will close for public subscription today. The public offer has received an
Continue reading